One prospective, multicenter study included 2482 women with BRCA1 or BRCA2 P/LP variants from 22 centers in Europe and North America to assess the relationship of risk-reducing mastectomy or salpingo-oophorectomy with cancer outcomes. This evidence concerns the gene BRCA2 and cancer.